Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life

Open access
Religioni, Urszula, Barrios-Rodríguez, Rocío, Requena, Pilar, Borowska, Mariola, Ostrowski, Janusz · 2025 · Medicina

Abstract

Adherence to therapy, defined as the extent to which a patient follows prescribed therapeutic recommendations, is a pivotal factor in the effective management of chronic diseases such as diabetes, hypertension, and cardiovascular conditions. This review highlights the profound influence of adherence on clinical outcomes, healthcare costs, and patient quality of life. Despite its critical importance, non-adherence remains a pervasive challenge globally, contributing to suboptimal treatment results, higher rates of complications, increased hospitalizations, and substantial healthcare expenditures. This narrative review examines the multifaceted impact of adherence, focusing on its role in achieving clinical efficacy, mitigating economic burdens, and enhancing patient well-being. The findings reveal that poor adherence exacerbates the risk of disease progression, complications, and higher healthcare costs. Conversely, improved adherence promotes better disease control, fewer complications, and enhanced patient quality of life. Interventions such as patient education, streamlined treatment regimens, and the integration of digital health tools have shown promise in addressing adherence barriers. Furthermore, the role of healthcare professionals is underscored as fundamental, with their continuous support, effective communication, and efforts to build patient trust being essential to fostering better adherence. In conclusion, adherence significantly affects clinical outcomes, healthcare costs, and patient quality of life. Addressing barriers to adherence requires a comprehensive and personalized approach, considering individual patient needs and circumstances. Future research should prioritize the long-term evaluation of emerging technologies and the development of tailored strategies to improve adherence across diverse patient populations. Strengthening adherence is not only crucial for individual patient outcomes, but also for enhancing the sustainability and efficiency of healthcare systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicina61010153

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 49

  1. Chong, B., Jayabaskaran, J., Jauhari, S.M., Chan, S.P., Goh, R., Kueh, M.T.W., Li, H., Chin, Y.H., Kong, G., and Anand, V.V. (2024). Global burden of cardiovascular diseases: Projections from 2025 to 2050. Eur. J. Prev. Cardiol., zwae281. · DOI · Paper page
  2. Cordioli, M., Corbetta, A., Kariis, H.M., Jukarainen, S., Vartiainen, P., Kiiskinen, T., Ferro, M., FinnGen, Estonian Biobank Research Team, and Perola, M. (2024). Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classes. Nat. Commun., 15. · DOI
  3. Lee, 2022, Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: A meta-analysis involving 27 million patients, J. Am. Heart Assoc., 11, e026582, 10.1161/JAHA.122.026582 · DOI · Paper page
  4. Iuga, 2014, Adherence and health care costs, Risk Manag. Healthc. Policy, 7, 35
  5. Maffoni, 2020, Medication adherence in the older adults with chronic multimorbidity: A systematic review of qualitative studies on patient’s experience, Eur. Geriatr. Med., 11, 369, 10.1007/s41999-020-00313-2 · DOI
  6. Nguyen, 2014, What are validated self-report adherence scales really measuring?: A systematic review, Br. J. Clin. Pharmacol., 77, 427, 10.1111/bcp.12194 · DOI · Paper page
  7. Gackowski, 2024, Innovative approaches to enhance and measure medication adherence in chronic disease management: A review, Med. Sci. Monit., 30, e944605, 10.12659/MSM.944605 · DOI
  8. Oliveira, 2023, Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: A systematic review and meta-analysis, Syst. Rev., 12, 222, 10.1186/s13643-023-02340-z · DOI
  9. Morowatisharifabad, 2019, Antiretroviral therapy adherence based on information, motivation, and behavioral skills model and its association with depression among HIV-positive patients: Health promotion strategy towards the 909090 target, J. Educ. Health Promot., 8, 192, 10.4103/jehp.jehp_42_19 · DOI
  10. Gimeno, 2024, Adherence and persistence to basal insulin among people with type 2 diabetes in Europe: A systematic literature review and meta-analysis, Diabetes Ther., 15, 1047, 10.1007/s13300-024-01559-w · DOI
  11. McKenzie, 2015, The burden of non-adherence to cardiovascular medications among the aging population in Australia: A meta-analysis, Drugs Aging, 32, 217, 10.1007/s40266-015-0245-1 · DOI
  12. Nielsen, 2017, Non-adherence to anti-hypertensive medication in low- and middle-income countries: A systematic review and meta-analysis of 92,443 subjects, J. Hum. Hypertens., 31, 14, 10.1038/jhh.2016.31 · DOI · Paper page
  13. Venditti, V., Bleve, E., Morano, S., and Filardi, T. (2023). Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites, 13. · DOI
  14. DiMatteo, 2012, Improving patient adherence: A three-factor model to guide practice, Health Psychol. Rev., 6, 74, 10.1080/17437199.2010.537592 · DOI · Paper page
  15. Ricke, E., Dijkstra, A., and Bakker, E.W. (2023). Prognostic factors of adherence to home-based exercise therapy in patients with chronic diseases: A systematic review and meta-analysis. Front. Sports Act. Living, 5. · DOI
  16. Turgeon, 2017, The dangers of polypharmacy in elderly patients, JAMA Intern. Med., 177, 1544, 10.1001/jamainternmed.2017.4790 · doi:10.1001/jamainternmed.2017.4790
  17. Bayatra, 2024, Overcoming low adherence to chronic medications by improving their effectiveness using a personalized second-generation digital system, Curr. Pharm. Biotechnol., 25, 2078, 10.2174/0113892010269461240110060035 · DOI
  18. Evans, 2022, Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review, Diabetes Obes. Metab., 24, 377, 10.1111/dom.14603 · DOI
  19. Perco, 2021, Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review, J. Diabetes Complicat., 35, 107931, 10.1016/j.jdiacomp.2021.107931 · DOI
  20. Piragine, E., Petri, D., Martelli, A., Calderone, V., and Lucenteforte, E. (2023). Adherence to oral antidiabetic drugs in patients with type 2 diabetes: Systematic review and meta-analysis. J. Clin. Med., 12. · DOI
  21. Kengne, 2024, Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: Systematic review, Expert Rev. Pharmacoecon. Outcomes Res., 24, 143, 10.1080/14737167.2023.2266135 · DOI
  22. Ihm, 2022, Interventions for adherence improvement in the primary prevention of cardiovascular diseases: Expert consensus statement, Korean Circ. J., 52, 1, 10.4070/kcj.2021.0226 · DOI
  23. Rupakheti, 2024, Treatment adherence and health-related quality of life among patients with hypertension at tertiary healthcare facility in Lalitpur, Nepal: A cross-sectional study, Patient Prefer. Adherence, 18, 2077, 10.2147/PPA.S476104 · DOI
  24. Jarrah, M., Khader, Y., Alkouri, O., Al-Bashaireh, A., Alhalaiqa, F., Al Marzouqi, A., Qaladi, O.A., Alharbi, A., Alshahrani, Y.M., and Alqarni, A.S. (2023). Medication adherence and its influencing factors among patients with heart failure: A cross-sectional study. Medicina, 59. · DOI
  25. Millenaar, 2021, Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY Trial), Am. J. Cardiol., 149, 27, 10.1016/j.amjcard.2021.03.024 · DOI
  26. Burnier, 2019, Adherence in hypertension, Circ. Res., 124, 1124, 10.1161/CIRCRESAHA.118.313220 · DOI · Paper page
  27. Baryakova, 2023, Overcoming barriers to patient adherence: The case for developing innovative drug delivery systems, Nat. Rev. Drug Discov., 22, 387, 10.1038/s41573-023-00670-0 · DOI · Paper page
  28. Elliott, 2017, Cost-effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: An economic evaluation of the New Medicine Service (NMS) compared with normal practice, Pharmacoeconomics, 35, 1237, 10.1007/s40273-017-0554-9 · DOI
  29. Adams, 2019, Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions, Res. Soc. Adm. Pharm., 15, 744, 10.1016/j.sapharm.2018.09.006 · DOI
  30. Bhuyan, 2017, Does cost-related medication nonadherence among cardiovascular disease patients vary by gender? Evidence from a nationally representative sample, Womens Health Issues, 27, 108, 10.1016/j.whi.2016.10.004 · DOI
  31. Rezaei, S., Peikanpour, M., Zarei, L., Mohammadnezhad, G., and Salamzadeh, J. (2023). An adapted model of cost-related medication nonadherence among older adult patients with chronic diseases: An Iranian qualitative study. BMC Geriatr., 23. · DOI
  32. Lee, 2018, Attitudes, beliefs, and cost-related medication nonadherence among adults aged 65 or older with chronic diseases, Prev. Chronic Dis., 15, E148, 10.5888/pcd15.180190 · DOI
  33. McElfish, 2018, Cost-related nonadherence to medication treatment plans: Native Hawaiian and Pacific Islander National Health Interview Survey, 2014, Med. Care, 56, 341, 10.1097/MLR.0000000000000887 · DOI
  34. Souza, 2016, Quality of life and treatment adherence in hypertensive patients: Systematic review with meta-analysis, Rev. Saude Publica, 50, 71, 10.1590/s1518-8787.2016050006415 · DOI
  35. Jansen, 2021, Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: A narrative review of the clinical and economic case for smart inhalers, J. Thorac. Dis., 13, 3846, 10.21037/jtd-20-2360 · DOI
  36. Khan, 2024, Treatment non-adherence patterns among patients with mental illness: A study from the district mental health care center in India, Cureus, 16, e54495
  37. Ameri, 2020, Effect of information, motivation, and behavioral skills model on adherence to medication, diet, and physical activity in HIV/ADIS patients: A health promotion strategy, J. Educ. Health Promot., 9, 317, 10.4103/jehp.jehp_188_20 · doi:10.4103/jehp.jehp_188_20
  38. 2022, Technology-based interventions to improve adherence to antihypertensive medications—An evidence-based review, Digit. Health, 8, 20552076221089725
  39. Peng, 2020, Effectiveness of mobile applications on medication adherence in adults with chronic diseases: A systematic review and meta-analysis, J. Manag. Care Spec. Pharm., 26, 550
  40. Choi, E.P.H. (2019). A pilot study to evaluate the acceptability of using a smart pillbox to enhance medication adherence among primary care patients. Int. J. Environ. Res. Public Health, 16. · DOI
  41. Leiz, 2022, Telemedicine as a tool to improve medicine adherence in patients with affective disorders—A systematic literature review, Patient Prefer. Adherence, 16, 3441, 10.2147/PPA.S388106 · DOI
  42. Elnaem, 2020, Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions, Patient Prefer. Adherence, 14, 2135, 10.2147/PPA.S268499 · DOI
  43. Marcum, 2021, Pharmacist-led interventions to improve medication adherence in older adults: A meta-analysis, J. Am. Geriatr. Soc., 69, 3301, 10.1111/jgs.17373 · DOI
  44. Conn, 2015, Packaging interventions to increase medication adherence: Systematic review and meta-analysis, Curr. Med. Res. Opin., 31, 145, 10.1185/03007995.2014.978939 · DOI · Paper page
  45. Kim, 2023, Effectiveness of nurse-led interventions on medication adherence in adults taking medication for metabolic syndrome: A systematic review and meta-analysis, J. Clin. Nurs., 32, 5328, 10.1111/jocn.16589 · DOI
  46. Zanforlini, B.M., Sambo, S., Devita, M., Cignarella, A., Vezzali, F., Sturani, S., Grandieri, A., Noale, M., Siviero, P., and Limongi, F. (2024). A multidisciplinary approach to improve adherence to medical recommendations in older adults at hospital discharge: The APPROACH study protocol. PLoS ONE., 19. · DOI
  47. Persaud, 2020, Effect on treatment adherence of distributing essential medicines at no charge: The CLEAN Meds randomized clinical trial, JAMA Intern. Med., 180, 27, 10.1001/jamainternmed.2019.4472 · DOI
  48. Farley, 2019, Are the benefits of value-based insurance design conclusive?, J. Manag. Care Spec. Pharm., 25, 736
  49. Dao, N., Lee, S., Hata, M., and Sarino, L. (2018). Impact of appointment-based medication synchronization on proportion of days covered for chronic medications. Pharmacy, 6. · DOI

Cited by

See all 215

Metadata

Authors
Religioni, U., Barrios-Rodríguez, R., Requena, P., Borowska, M., & Ostrowski, J.
Venue
Medicina
Publisher
MDPI AG
Published
2025-01-17
Volume
61
Issue
1
Pages
153
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W4406526186
Cited by
215
References
10
FWCI
235.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. https://app.cochat.ai/papers/10.3390/medicina61010153
The paper
Religioni, U., Barrios-Rodríguez, R., Requena, P., Borowska, M., & Ostrowski, J. (2025). Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life. Medicina. https://doi.org/10.3390/medicina61010153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.